BUSINESS● LOWSep 15 · Sep 15, 2026, 6:30 AM
GSK expands myeloma pipeline in deal worth up to $750M
Seeking Alpha Tech · global
GSK is expanding its myeloma pipeline through a deal valued at up to $750 million. This business transaction indicates strategic growth in the pharmaceutical company's cancer research and development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS14m agoGermany Inflation Eases to 2.8% in OctoberSeeking Alpha TechBUSINESS14m ago4 stocks to watch on Friday: AMZN, XOM, CVX, and SNDKSeeking Alpha Tech